This inventor holds 2 USPTO granted patents and 1 published patent application, plus 1 CIPO patent and 2 EPO patents. Top assignees: Japanese Foundation for Cancer Research, Kabushiki Kaisha Yakult Honsha, Riken Corporation. Active years: 2022-2023.
Company Filing History:
2 out of 57 
2 out of 215 
2 out of 888 
Years Active: 2022-2023
Title: Yoko Yashiroda: Innovator in Pharmaceutical Research
Introduction
Yoko Yashiroda is a prominent inventor based in Wako, Japan. She has made significant contributions to the field of pharmaceutical research, particularly in the development of compounds that have potential therapeutic applications. With a total of two patents to her name, Yashiroda's work is recognized for its innovative approach to drug development.
Latest Patents
Yashiroda's latest patents include a dihydroquinazolinone compound or pharmacologically acceptable salt, which has implications for various medical treatments. Additionally, she has developed a cell growth inhibitor characterized by a compound formula that includes several unique structures. These compounds are designed to inhibit cell proliferation, showcasing her commitment to advancing cancer research and treatment options.
Career Highlights
Throughout her career, Yoko Yashiroda has worked with esteemed organizations such as Riken Corporation and the Japanese Foundation for Cancer Research. Her experience in these institutions has allowed her to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
Yashiroda has collaborated with notable colleagues, including Minoru Yoshida and Hiroyuki Seimiya. These partnerships have enriched her research and expanded the impact of her inventions in the scientific community.
Conclusion
Yoko Yashiroda's innovative work in pharmaceutical research exemplifies her dedication to improving health outcomes through her inventions. Her patents reflect a deep understanding of complex chemical compounds and their potential applications in medicine.